LDS/Medical Tests/Dehydroepiandrosterone (DHEA)

Dehydroepiandrosterone (DHEA)

Dehydroepiandrosterone (DHEA) is a steroid secreted by the adrenal cortex, and is a precursor in testosterone and estrogen biosynthesis. Due to the presence of a 17-oxo (rather than hydroxyl) group, DHEA possesses relatively weak androgenic activity, which has been estimated at ~10% that of testosterone. Abnormal levels have been reported in obesity and schizophrenia. Excessive DHEA secretion can cause acne, hirsutism and virilization. DHEA measurement is important in the investigation of adrenal androgen production for adrenal hyperplasia and tumors. DHEA has a fast clearance turnover rate compared to its sulfated conjugate. This leads to a marked difference in circulation concentration compared to the sulfate derivative, which has a much longer half life. DHEA levels do show circadian rhythm that reflects the secretion of ACTH and also varies during the menstrual cycle. Measurement of serum DHEA is a useful marker of adrenal androgen synthesis. Since very little DHEA is produced in by the gonads, measurement of DHEA may aid in the localization of the androgen source in virilizing conditions.

  • Diagnosis of virilizing adrenal adenoma
  • As an aid in diagnosis of adrenal carcinoma
  • Hormone therapy monitoring
  • Aids in diagnosis of hirsutism, virilism, and hyperandrogenism
  • Helpful in excluding adrenal tumors
  • Excellent indicator of adrenal cortex androgen production

Increase in:

  • Elevated DHEA levels indicate increased adrenal androgen production
  • Virilizing adrenal neoplasm
  • Female hirsutism (usually adrenal cause)
  • In congenital adrenal hyperplasias

Decreased in:

  • Adrenal insufficiency
  • Decreased with age
  • Hypoadrenalism
Age Group Reference Value (ng/mL)
Premature < 40
0–1 day < 11
2–6 days < 8.7
7 days–1 month < 5.8
2–23 months < 2.9
2–5 years < 2.3
6–10 years < 3.4
11–14 years < 5.0
15–18 years < 6.6
19–30 years < 13
31–40 years < 10
41–50 years < 8.0
51–60 years < 6.0
≥ 61 years < 5.0

 

Enzyme Immunoassay, Chemiluminescence.

Serum (SST) or plasma

Stability

  • Ambient: 7 days
  • Refrigerated: 7 days
  • Frozen: 6 months
DHEA-S, Serum Testosterone, Free and Total, Sex Hormone Blinding Globulin, Androstenedione, FSH, Adrenocorticotropic Hormone, Cortisol, Estradiol, 17-hydroxyprogesterone.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Clin Endcrinol Metab. 1978;47: 572-577. [PMID: 162515]
  • Fertil Steril. 2002 Apr;77 Suppl 4: S3-5. [PMID: 12007895]
  • Endocr Rev. 1984 Fall;5(4): 498-513. [PMID: 6094172]
  • Fertil Steril. 2002 Apr;77 Suppl 4: S19-25. [PMID: 12007898]
  • J Clin Endocrinol Metab. 1991;73: 674-686. [PMID: 1651957]
  • Pediatric. 1985;76: 437-444. [PMID: 3162151]
  • J Clin Endocrinol Metab. 1985;60: 428-439. [PMID: 2982896]
  • J Clin Endocrinol Metab. 1980;51: 330-333. [PMID: 6447161]
  • Pang S, Riddick L: Hirsutism. In Lifshitz F (Ed): Pediatric Endocrinology, A Clinical Guide, second edition. Marcel Dekker, Inc., New York, 1990, pp. 259-291.
  • SJ Soldin, C Brugnara, EC Wong (eds). Dehydroepiandrosterone. In Pediatric Reference Ranges, 5th edition. Washington, DC, AACC Press, 2005, p 75.
  • Dorfman RI, Shipley RA. Androgens, John Wiley and Sons, New York, 1956, pp. 116-128.